News | Artificial Intelligence | December 13, 2022

The secure nationwide AI-powered cloud platform streamlines care team communication and delivers patient-specific imaging insights within clinical workflows

The secure nationwide AI-powered cloud platform streamlines care team communication and delivers patient-specific imaging insights within clinical workflows

December 13, 2022 — Densitas Inc., a global provider of AI solutions for digital mammography and breast screening, today announced that it has connected to the Nuance Precision Imaging Network (PIN), a secure nationwide cloud platform empowering collaborative care teams with streamlined communications and workflow-integrated AI insights from diagnostic imaging to improve healthcare outcomes and costs. 

Densitas intelliMammo, comprising intelliMammo densityAI, qualityAI, and riskAI, offers a FDA/ACR compliant solution for clinical and enterprise decision-making that includes breast density, breast cancer risk, and clinical image quality. IntelliMammo presents clinical care teams with on-demand actionable information and digitized workflows to systematically improve mammography quality, organizational and workflow efficiencies, and support early breast cancer detection and treatment. 

Leveraging the nationwide scale of the Nuance PowerScribe and Nuance PowerShare diagnostic imaging solutions, the Nuance Precision Imaging Network connects radiologists, providers, health plans, self-insured employers, life science companies, and other imaging stakeholders to broaden access to precision diagnostics and therapeutics, increase healthcare efficiency, and lower costs. It enables secure and seamless sharing of AI insights from diagnostic imaging to enhance clinical decision-making, enhance care team collaboration, and facilitate the earlier detection and treatment of diseases for improved patient outcomes. 

"Our intelliMammo platform provides a solid foundation for population health management as patients navigate through breast cancer screening, diagnostic, treatment, and prevention pathways," said Mo Abdolell, CEO, of Densitas. "Through the Nuance Precision Imaging Network, intelliMammo becomes immediately accessible to over 10,000 healthcare facilities across the US. The addition of intelliMammo opens the door to Nuance customers to capture information from routine screening mammograms and seamlessly leverage patient-centered data and insights in their existing clinical and administrative workflows." 

"We're proud to support Densitas with seamless workflow-integrated access through the Nuance Precision Imaging Network, providing powerful clinical decision support tools at the point-of-care as they advance their important work in breast cancer screening," said Roland Dias, Vice President, Precision Imaging Network, Nuance. 

For more information: www.densitas.com 

 

Find more RSNA22 coverage here 


Related Content

News | RSNA

May 29, 2024 — The Radiological Society of North America (RSNA) has launched the 2024 RSNA Lumbar Spine Degenerative ...

Time May 29, 2024
arrow
News | Breast Imaging

May 28, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time May 28, 2024
arrow
News | Radiology Education

May 24, 2024 — The American Society of Radiologic Technologists (ASRT) has announced that its ASRT Foundation has ...

Time May 24, 2024
arrow
News | Enterprise Imaging

May 24, 2024 — International medical imaging IT and cybersecurity company Sectra’s enterprise imaging solution has been ...

Time May 24, 2024
arrow
News | Lung Imaging

May 24, 2024 — Smokers who have small abnormalities on their CT scans that grow over time have a greater likelihood of ...

Time May 24, 2024
arrow
News | Artificial Intelligence

May 23, 2024 — NewVue.ai, born from the radiology technology pioneers behind peerVue and recognized as a trailblazer in ...

Time May 23, 2024
arrow
News | Radiation Therapy

May 23, 2024 — RaySearch Laboratories AB and C-RAD announced a collaboration agreement, aiming at jointly developing ...

Time May 23, 2024
arrow
News | FDA

May 22, 2024 — The U.S. Food and Drug Administration (FDA) has issued a recall of the Hologic Inc. BioZorb marker due to ...

Time May 22, 2024
arrow
News | Artificial Intelligence

May 22, 2024 — Lunit, a provider of Artificial intelligence (AI)-powered solutions for cancer diagnostics and ...

Time May 22, 2024
arrow
News | ASTRO

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
Subscribe Now